Lincoln Pharma Financials
NSE: LINCOLN | BSE: 531633
₹543.50
₹-14.80
(-2.65%)
As on 12-Oct-2026IST
Market cap
₹1,090 Cr
Revenue (TTM)
₹694 Cr
P/E Ratio
11.3
P/B Ratio
1.4
Div. Yield
0.3 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
694.25
|
671.03
|
623.23
|
580.55
|
510.31
|
472.12
|
|
|
|
|
|
|
Total Income
|
736.69
|
704.48
|
645.71
|
614.97
|
532.78
|
482.12
|
|
|
|
|
|
|
Total Expenditure
|
592.94
|
573.35
|
521.74
|
480.64
|
421.11
|
376.64
|
|
|
|
|
|
|
EBITDA
|
101.31
|
97.68
|
101.49
|
99.91
|
89.20
|
95.48
|
|
|
|
|
|
|
Depreciation
|
14.91
|
14.50
|
12.90
|
10.62
|
9.17
|
8.09
|
|
|
|
|
|
|
EBIT
|
86.40
|
83.18
|
88.59
|
89.29
|
80.04
|
87.39
|
|
|
|
|
|
|
Interest
|
1.06
|
1.01
|
1.88
|
1.46
|
2.03
|
1.45
|
|
|
|
|
|
|
Other Income
|
42.45
|
33.45
|
22.48
|
34.42
|
22.47
|
10.00
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
127.79
|
115.63
|
109.19
|
122.24
|
100.48
|
95.94
|
|
|
|
|
|
|
Provision for Tax
|
31.34
|
27.73
|
26.84
|
28.94
|
27.58
|
26.58
|
|
|
|
|
|
|
Profit after Tax
|
96.45
|
87.89
|
82.35
|
93.30
|
72.90
|
69.36
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
96.45
|
87.89
|
82.35
|
93.30
|
72.90
|
69.36
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
757.63
|
757.63
|
671.67
|
592.84
|
502.47
|
432.88
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
21.73
|
21.73
|
19.12
|
15.18
|
38.02
|
10.99
|
|
|
|
|
|
|
Current Liabilities
|
111.05
|
136.76
|
131.09
|
117.41
|
96.01
|
110.71
|
|
|
|
|
|
|
Total Liabilities
|
890.41
|
916.12
|
821.88
|
725.42
|
636.51
|
554.58
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
302.96
|
307.35
|
297.07
|
262.51
|
245.42
|
181.51
|
|
|
|
|
|
|
Current Assets
|
583.06
|
608.77
|
524.81
|
462.91
|
391.08
|
373.07
|
|
|
|
|
|
|
Total Assets
|
890.41
|
916.12
|
821.88
|
725.42
|
636.51
|
554.58
|
|
|
|
|
|
|
Total Debt*
|
--
|
4.42
|
--
|
1.07
|
2.00
|
2.04
|
|
|
|
|
|
|
Net Current Assets
|
472.01
|
472.01
|
393.72
|
345.50
|
295.07
|
262.36
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
4.48
|
3.12
|
0.23
|
0.23
|
0.23
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
106.36
|
93.02
|
63.22
|
39.26
|
76.13
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-98.41
|
-78.95
|
-57.34
|
-36.64
|
-78.08
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
0.16
|
-6.40
|
-5.18
|
-4.50
|
-2.56
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
8.11
|
7.67
|
0.70
|
-1.88
|
-4.50
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
48.15
|
43.88
|
41.11
|
46.58
|
36.40
|
34.63
|
|
|
|
|
|
|
Cash EPS (₹)
|
48.15
|
51.12
|
47.55
|
51.89
|
40.97
|
38.66
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
396.34
|
378.25
|
335.34
|
295.98
|
250.86
|
216.12
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.33
|
1.80
|
1.80
|
1.80
|
1.50
|
1.50
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
53.10
|
46.44
|
31.56
|
19.60
|
38.01
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
42.89
|
42.52
|
24.06
|
18.18
|
17.14
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
16.27
|
17.55
|
22.53
|
21.82
|
24.29
|
|
|
|
|
|
|
ROE (%)
|
13.09
|
12.30
|
13.02
|
17.04
|
15.59
|
17.35
|
|
|
|
|
|
|
ROA (%)
|
11.43
|
10.11
|
10.64
|
13.70
|
12.24
|
13.31
|
|
|
|
|
|
|
EBIT Margin (%)
|
12.45
|
12.40
|
14.22
|
15.38
|
15.68
|
18.51
|
|
|
|
|
|
|
Net Margin (%)
|
13.09
|
12.48
|
12.75
|
15.17
|
13.68
|
14.39
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
14.61
|
14.59
|
17.12
|
15.35
|
15.60
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
10.19
|
7.67
|
7.35
|
13.76
|
8.09
|
11.30
|
|
|
|
|
|
|
EBIT Growth (%)
|
-3.37
|
-6.11
|
-0.77
|
11.55
|
-8.42
|
9.76
|
|
|
|
|
|
|
Net Profit Growth (%)
|
11.70
|
6.74
|
-11.74
|
27.99
|
5.11
|
11.41
|
|
|
|
|
|
|
EPS Growth (%)
|
11.70
|
6.74
|
-11.75
|
27.99
|
5.11
|
11.41
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
12.80
|
13.30
|
17.98
|
16.08
|
18.15
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
11.30
|
12.86
|
13.42
|
12.57
|
9.31
|
8.98
|
|
|
|
|
|
|
Price / Book Value
|
1.37
|
1.49
|
1.64
|
1.98
|
1.35
|
1.44
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.33
|
0.32
|
0.33
|
0.31
|
0.44
|
0.48
|
|
|
|
|
|
|
EV/EBITDA
|
7.39
|
8.40
|
8.73
|
8.63
|
5.79
|
5.75
|
|
|
|
|
|
|
Close Price (₹)
|
623.50
|
564.95
|
551.50
|
586.05
|
339.25
|
310.60
|
|
|
|
|
|
|
High Price (₹)
|
770.00
|
679.45
|
979.50
|
755.15
|
379.90
|
414.75
|
|
|
|
|
|
|
Low Price (₹)
|
439.95
|
439.95
|
498.00
|
328.75
|
255.00
|
221.30
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
1,090.12
|
1,130.35
|
1,104.74
|
1,172.54
|
678.40
|
623.02
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.01
|
--
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.01
|
--
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
Current Ratio
|
5.25
|
4.45
|
4.00
|
3.94
|
4.07
|
3.37
|
|
|
|
|
|
|
Quick Ratio
|
4.53
|
3.87
|
3.40
|
3.29
|
3.34
|
2.71
|
|
|
|
|
|
|
Interest Coverage
|
121.33
|
115.14
|
58.99
|
84.45
|
50.50
|
67.11
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
23.26
|
24.06
|
26.70
|
27.86
|
26.72
|
24.56
|
|
|
|
|
|
|
Asset Turnover
|
0.82
|
0.81
|
0.84
|
0.89
|
0.90
|
0.95
|
|
|
|
|
|
|
Receivable days
|
--
|
85.34
|
91.75
|
89.63
|
86.09
|
84.27
|
|
|
|
|
|
|
Inventory Days
|
--
|
41.33
|
43.57
|
44.26
|
48.72
|
43.86
|
|
|
|
|
|
|
Payable days
|
--
|
146.25
|
141.73
|
110.27
|
124.63
|
138.44
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-19.58
|
-6.41
|
23.61
|
10.19
|
-10.30
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
